Advertisements


Opioid maker Insys to be delisted from NASDAQ following bankruptcy filing

Opioid maker Insys Therapeutics, Inc. shares will be delisted on the Nasdaq on June 19, the company said in a government filing on Tuesday......»»

Category: topSource: moneycentralJun 12th, 2019

Opioid maker Insys to be delisted from NASDAQ following bankruptcy filing

Opioid maker Insys Therapeutics, Inc. shares will be delisted on the Nasdaq on June 19, the company said in a government filing on Tuesday......»»

Category: topSource: moneycentralJun 12th, 2019

Chandler opioid maker files for bankruptcy protection

A troubled Chandler-based pharmaceutical firm that has been at the center of ongoing lawsuits and other action related to the national opioid epidemic has filed for bankruptcy protection. In a regulatory filing Monday, Insys Therapeutics (Nasdaq: .....»»

Category: topSource: bizjournalsJun 10th, 2019

Troubled Chandler opioid maker sells off drug assets as part of bankruptcy

Insys Therapeutics Inc, has entered into sales agreements to unload some of its drug assets for a combined $29.2 million as the Chandler-based pharmaceutical firm works through bankruptcy filing proceedings. Insys will sell its naloxone and epinephrin.....»»

Category: topSource: bizjournalsAug 23rd, 2019

Exclusive: Purdue Pharma nears partial opioid settlement, bankruptcy filing - sources

OxyContin maker Purdue Pharma LP is nearing a partial.....»»

Category: topSource: reutersSep 11th, 2019

Opioid talks fail, Purdue bankruptcy filing expected

OxyContin maker Purdue Pharma is expected to file for bankruptcy after settlement talks over the nation's deadly overdose crisis hit an impasse, attorneys general involved in the talks said Saturday......»»

Category: topSource: moneycentralSep 8th, 2019

Breaking: iPic stock to be delisted from Nasdaq

The SEC filing pointed to iPic's recent bankruptcy filing as reason for the delisting......»»

Category: topSource: bizjournalsAug 8th, 2019

What Insys Therapeutics Gets by Filing for Chapter 11

Fentanyl-maker Insys Therapeutics has filed for bankruptcy protection while the company sells all its assets......»»

Category: blogSource: 247wallstJun 10th, 2019

Opioid maker Insys Therapeutics files Chapter 11 bankruptcy after corruption charges

Pharmaceutical company Insys Therapeutics filed for Chapter 11 bankruptcy protection Monday less than a week after pleading .....»»

Category: topSource: usatodayJun 10th, 2019

Insys Shares Fall 70% After Filing For Chapter 11 Bankruptcy

Insys Therapeutics, Inc. (NASDAQ: INSY) shares are trading sharply lower following news the company initiated a court supervised process to facilitate asset sales via Chapter 11 bankruptcy. read more.....»»

Category: blogSource: benzingaJun 10th, 2019

Insys Plunges 70% After Bankruptcy Warning

Opioid drugmaker Insys Therapeutics Inc (NASDAQ: INSY) may soon go bust, the company suggested in the first-quarter earnings report it released Friday after the close. read more.....»»

Category: blogSource: benzingaMay 13th, 2019

Insys stock drops 27% after auditor questions company"s viability

Shares of opioid maker Insys Therapeutics Inc. dropped 27% on Wednesday after the company disclosed in a securities filing that an audito.....»»

Category: topSource: marketwatchMar 13th, 2019

Purdue Pharma seeks to halt opioid suits against company, Sacklers

OxyContin maker Purdue Pharma LP on Wednesday asked a U.S. bankruptcy judge to halt for roughly nine months more than 2,600 lawsuits alleging the company and its controlling Sackler family helped fuel the U.S. opioid crisis, according to court documents......»»

Category: topSource: reutersSep 18th, 2019

Purdue Pharma to stay in business as bankruptcy unfolds

A judge cleared the way Tuesday for OxyContin maker Purdue Pharma to stay in business while it pursues bankruptcy protection and settlement of more than 2,600 lawsuits filed against it in a reckoning over the opioid crisis......»»

Category: topSource: moneycentralSep 18th, 2019

Oxycontin maker Purdue begins bankruptcy in push to settle opioid lawsuits

OxyContin maker Purdue Pharma LP is expected in court on Tuesday to lay out its plan for using bankruptcy to resolve more than 2,600 lawsuits alleging the company fueled the U.S. opioid crisis......»»

Category: topSource: reutersSep 17th, 2019

What"s next for OxyContin maker Purdue Pharma

OxyContin maker Purdue Pharma LP filed for bankruptcy protection after reaching a partial deal to resolve more than 2,600 lawsuits alleging it helped fuel the U.S. opioid crisis......»»

Category: topSource: reutersSep 16th, 2019

Factbox: What"s next for OxyContin maker Purdue Pharma

OxyContin maker Purdue Pharma LP filed for bankruptcy protection after reaching a partial deal to resolve more than 2,600 lawsuits alleging it helped fuel the U.S. opioid crisis......»»

Category: topSource: reutersSep 16th, 2019

OxyContin maker Purdue Pharma files for bankruptcy

Purdue Pharma, the narcotics manufacturer blamed for triggering America‚Äôs opioid crisis through its aggressive marketing of the highly addictive painkiller OxyContin, filed for bankruptcy Sunday......»»

Category: topSource: moneycentralSep 16th, 2019

OxyContin maker files for bankruptcy

Purdue Pharma, the company behind OxyContin, filed for bankruptcy protection Sunday night (September 15), amid more than 2,600 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic. Ryan Brooks reports......»»

Category: videoSource: reutersSep 16th, 2019

OxyContin maker Purdue Pharma files for bankruptcy protection

OxyContin maker Purdue Pharma LP filed for bankruptcy protection in New York Sunday night, succumbing to pressure from more than 2,000 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic......»»

Category: topSource: reutersSep 15th, 2019

Opioid maker Purdue Pharma files for bankruptcy amid lawsuits

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchSep 15th, 2019